French microbiologist Emmanuelle Charpentier, who was named a co-winner of the second Tang Prize in biopharmaceutical science on Sunday for her work in the development of CRISPR/Cas9, said she hopes the genome editing technology can be used to treat currently incurable conditions.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Murder charge dropped in case of teenage millionaire's death
05/01/2025 04:29 PM - Business
3 firms enforce furloughs due to U.S. tariff impact
05/01/2025 03:52 PM - Politics
Cabinet approves draft amendment to extend tax rebates for appliances
05/01/2025 03:37 PM - Politics
Taiwan to send team to Geneva despite no invitation to WHA event
05/01/2025 03:30 PM - Society
Fugitive Taiwanese blogger repatriated on suspicion of fraud
05/01/2025 02:42 PM